Quick Answer
AXIM BIOTECHNOLOGIES, INC. reported Net Income of -$8.06 million for fiscal year 2023.
AXIM BIOTECHNOLOGIES, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2023 | -$8.06M | -29.1% |
| 2022 | -$6.24M | +61.1% |
| 2021 | -$16.03M | -137.4% |
| 2018 | -$6.75M | -62.1% |
| 2017 | -$4.17M | +28.3% |
| 2016 | -$5.81M | -896.6% |
| 2014 | -$582.9K | -553.4% |
| 2013 | -$89.2K | -498.6% |
| 2012 | -$14.9K | -433.4% |
| 2011 | -$2.8K | -33.0% |
| 2010 | -$2.1K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | -$2.27M | +39.0% | -676.5% |
| March 31, 2024 | -$292.3K | +89.4% | -189.0% |
| September 30, 2023 | $328.5K | +116.1% | +108.8% |
| June 30, 2023 | -$3.72M | -204.5% | -34.8% |
| March 31, 2023 | -$2.76M | -32.4% | -35.8% |
| September 30, 2022 | -$2.03M | +38.2% | -66.4% |
| June 30, 2022 | -$1.22M | +68.1% | +41.4% |
| March 31, 2022 | -$2.09M | -141.4% | +36.6% |
- AXIM BIOTECHNOLOGIES, INC. showed a decrease of -29.1% in Net Income compared to the prior fiscal year.
- Over the 2010–2023 period, AXIM BIOTECHNOLOGIES, INC.’s net income has declined by 383694.4% (from -$2.1 thousand to -$8.06 million).
- The most recent figure is from AXIM BIOTECHNOLOGIES, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: